TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$4.50
−0.66%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
47.3x
Market Cap
$619.11M
MomentumView details →
1D Return
−0.66%
YTD Return
−49.92%
RSI (14)
48.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
47.3x
Market Cap
$619.11M
RSI (14)
48.1
MomentumView details →
1D Return
−0.66%
YTD Return
−49.92%
SummaryUpdated May 1, 2026
Tilray Brands, Inc. (NASDAQ:TLRY) is a Canadian multinational cannabis and consumer packaged goods company founded in 2013 and headquartered in Leamington, Ontario. Originally established as a medical cannabis producer, Tilray went public in 2018 and has since transformed into a diversified lifestyle brands company through strategic acquisitions and international expansion. The company operates across four main business segments: cannabis, beverage alcohol, distribution, and wellness products, serving markets in over 20 countries including Canada, the United States, Europe, Australia, and Latin America.
Similar companies
Latest newsMore news →
Tilray Brands announced it is increasing its annual cultivation capacity by 30 percent to meet accelerating international medical cannabis demand.15d agoMontauk Brewing Company opened its second brewpub location in Port Jefferson, New York, expanding its coastal footprint on Long Island.18d agoMontauk Brewing Company, a Tilray Brands subsidiary, announced the release of The Morning Brew, a limited-edition blonde ale created in collaboration with media company Morning Brew Inc.23d ago